ARE ANTIOSTEOPOROTIC DRUGS EFFECTIVE IN THE MANAGEMENT OF OSTEOARTHRITIS?

ARE ANTIOSTEOPOROTIC DRUGS EFFECTIVE IN THE MANAGEMENT OF OSTEOARTHRITIS?

Библиографические подробности
Главный автор:	Cooper, C
Формат:	Conference item
Опубликовано:	2013

Схожие документы

The antiosteoporotic effect of oxymatrine compared to testosterone in orchiectomized rats
по: Anwaar M. Shaban, и др.
Опубликовано: (2025-01-01)

The study of antiosteoporotic action of nanoparticulated resveratrol and losartan
по: N. U. Koklina, и др.
Опубликовано: (2014-12-01)

Calcium Phosphate/Hyaluronic Acid Composite Hydrogels for Local Antiosteoporotic Drug Delivery
по: Alise Svarca, и др.
Опубликовано: (2022-07-01)

Repurposing the Strontium Ranelate Antiosteoporotic Drug as a New Outstanding Biocompatible Blue Dye
по: Luca M. Sihn, и др.
Опубликовано: (2023-09-01)

Isolation of antiosteoporotic compounds from seeds of Sophora japonica.
по: Hossam M Abdallah, и др.
Опубликовано: (2014-01-01)

Antiosteoporotic Activity of Anthraquinones from Morinda officinalis on Osteoblasts and Osteoclasts
по: Cheng-Jian Zheng, и др.
Опубликовано: (2009-01-01)

Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-Osteoporotic Drugs (Part II). The Effect of Antiosteoporotic Drugs on the Vascular Wall State
по: I. A. Skripnikova, и др.
Опубликовано: (2019-07-01)

Antiosteoporotic effects of Alpinia officinarum Hance through stimulation of osteoblasts associated with antioxidant effects
по: Yanjie Su, и др.
Опубликовано: (2016-01-01)

Variation in Antiosteoporotic Drug Prescribing and Spending Across Spain. A Population-Based Ecological Cross-Sectional Study
по: Gabriel Sanfélix-Gimeno, и др.
Опубликовано: (2018-04-01)

Discovery of a Potent Antiosteoporotic Drug Molecular Scaffold Derived from Angelica sinensis and Its Bioinspired Total Synthesis
по: Jian Zou, и др.
Опубликовано: (2024-02-01)

Study on the antioxidant and antiosteoporotic activities of the oyster peptides prepared by ultrasound-assisted enzymatic hydrolysis
по: Zhengze Quan, и др.
Опубликовано: (2025-01-01)

Treatment thresholds and minimal clinically important effect sizes of antiosteoporotic medication-Survey among physicians and lay persons in Germany.
по: Piet van der Keylen, и др.
Опубликовано: (2022-01-01)

Potential antiosteoporotic effect of ginkgo biloba extract via regulation of SIRT1-NF-kB signaling pathway
по: Zhuoze Li, и др.
Опубликовано: (2020-06-01)

Antiosteoporotic activity of lupeol on postmenopausal symptoms through promoting estrogenic activity and bone markers in ovariectomized rats
по: Tanmayee Bhalerao, и др.
Опубликовано: (2024-11-01)

Association of Antiosteoporotic Medication Bisphosphonates and Denosumab with Primary Breast Cancer: An Electronic Health Record Cohort Study
по: Alexander Stanoyevitch, и др.
Опубликовано: (2021-08-01)

Comparing the Efficacy of Antiosteoporotic Drugs in Preventing Periprosthetic Bone Loss Following Total Hip Arthroplasty: A Systematic Review and Bayesian Network Meta‐Analysis
по: Yi Tang, и др.
Опубликовано: (2024-10-01)

PARAMETERS OF BONE METABOLISM IN PRE-AND POSTMENOPAUSAL WOMEN WITH TYPE 2 DIABETES MELLITUS IN THE RATIONALE FOR THE CHOICE OF ANTIOSTEOPOROTIC THERAPY
по: L A Ruyatkina, и др.
Опубликовано: (2013-12-01)

Antiosteoporotic Effects and Proteomic Characterization of the Target and Mechanism of an Er-Xian Decoction on Osteoblastic UMR-106 and Osteoclasts Induced From RAW264.7
по: Yu-Shan Li, и др.
Опубликовано: (2010-07-01)

Antidiabetic and antiosteoporotic pharmacotherapies for prevention and treatment of type 2 diabetes-induced bone disease: protocol for two network meta-analyses
по: Stephanie Sanger, и др.
Опубликовано: (2020-01-01)

Overuse and Underuse of Antiosteoporotic Treatments According to Highly Influential Osteoporosis Guidelines: A Population-Based Cross-Sectional Study in Spain.
по: Gabriel Sanfélix-Gimeno, и др.
Опубликовано: (2015-01-01)

Evaluation of bone tissue remodeling and mineral metabolism in elderly patients who have not been previously examined and have received no antiosteoporotic therapy
по: S B Malichenko, и др.
Опубликовано: (2012-03-01)

Evaluation of bone tissue remodeling and mineral metabolism in elderly patients who have not been previously examined and have received no antiosteoporotic therapy
по: S B Malichenko, и др.
Опубликовано: (2012-03-01)

Reaction of 3-Amino-1,2,4-Triazole with Diethyl Phosphite and Triethyl Orthoformate: Acid-Base Properties and Antiosteoporotic Activities of the Products
по: Patrycja Miszczyk, и др.
Опубликовано: (2017-02-01)

Bioregulatory drugs in osteoarthritis management
по: O. A. Shavlovskaya
Опубликовано: (2019-03-01)

Ligustrum japonicum Thunb. Fruits Exert Antiosteoporotic Properties in Bone Marrow-Derived Mesenchymal Stromal Cells via Regulation of Adipocyte and Osteoblast Differentiation
по: Jung Hwan Oh, и др.
Опубликовано: (2021-01-01)

Medical management of osteoarthritis
по: Walker-Bone, K, и др.
Опубликовано: (2000)

AN IN VITRO ANTIOSTEOPOROTIC ACTIVITY OF 96% ETHANOL EXTRACT OF Abelmoschus manihot L. MEDIK LEAVES USING MC3T3-E1 PREOSTEOBLAST CELLS
по: Agnis Pondinekaria Aditama, и др.
Опубликовано: (2016-12-01)

ANTI-INFLAMMATORY DRUGS IN MANAGEMENT OF KNEE OSTEOARTHRITIS
по: Usman Aziz, и др.
Опубликовано: (2019-04-01)

Regular review: medical management of osteoarthritis.
по: Walker-Bone, K, и др.
Опубликовано: (2000)

Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system
по: Bruyère, O, и др.
Опубликовано: (2008)

NEW PERSPECTIVES IN THE TREATMENT OF OSTEOARTHRITIS
по: Cooper, C
Опубликовано: (2012)

NEW PERSPECTIVES IN THE TREATMENT OF OSTEOARTHRITIS
по: Cooper, C
Опубликовано: (2012)

Excess mortality in osteoarthritis.
по: Cooper, C, и др.
Опубликовано: (2011)

Excess mortality in osteoarthritis.
по: Cooper, C, и др.
Опубликовано: (2011)

Topical NSAIDs in osteoarthritis.
по: Cooper, C, и др.
Опубликовано: (2004)

Cardiovascular Drugs and Osteoarthritis: Effects of Targeting Ion Channels
по: Raminta Vaiciuleviciute, и др.
Опубликовано: (2021-09-01)

Controversy About Management of Osteoarthritis with Disease-modifying Anti-rheumatic Drugs
по: CUI Hanshu, и др.
Опубликовано: (2025-01-01)

Strategy for the management of osteoarthritis in multimorbid patients: the balance of effectiveness and safety while choosing drug therapy
по: K. Yu. Belova, и др.
Опубликовано: (2020-08-01)

Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system
по: Rizzoli René, и др.
Опубликовано: (2008-12-01)

Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy
по: O. A. Shavlovskaya, и др.
Опубликовано: (2023-11-01)